Andreas Pircher

8.2k total citations · 1 hit paper
103 papers, 3.4k citations indexed

About

Andreas Pircher is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Andreas Pircher has authored 103 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Molecular Biology, 42 papers in Oncology and 41 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Andreas Pircher's work include Cancer Immunotherapy and Biomarkers (18 papers), Angiogenesis and VEGF in Cancer (18 papers) and Lung Cancer Treatments and Mutations (18 papers). Andreas Pircher is often cited by papers focused on Cancer Immunotherapy and Biomarkers (18 papers), Angiogenesis and VEGF in Cancer (18 papers) and Lung Cancer Treatments and Mutations (18 papers). Andreas Pircher collaborates with scholars based in Austria, Germany and Switzerland. Andreas Pircher's co-authors include Dominik Wolf‎, Peter Carmeliet, Bernard Thienpont, Isabel Heidegger, Lena Horvath, Wolfgang Hilbe, Renate Pichler, Sara Aibar, Kathleen Van den Eynde and Oliver T. Burton and has published in prestigious journals such as Nucleic Acids Research, Journal of Clinical Investigation and Nature Medicine.

In The Last Decade

Andreas Pircher

98 papers receiving 3.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Phenotype molding of stromal cells in the lung tumor microenvironment

2018 1.0k citations Diether Lambrechts, Els Wauters et al. Nature Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Andreas Pircher Austria	27	1.7k	1.5k	931	871	855	103	3.4k
Zaoqu Liu China	32	1.5k 0.9×	1.2k 0.8×	1.1k 1.2×	826 0.9×	1.2k 1.4×	142	3.4k
Marleen Kok Netherlands	30	1.1k 0.7×	2.3k 1.5×	887 1.0×	953 1.1×	817 1.0×	90	3.6k
Anushka Dongre United States	11	2.0k 1.2×	1.8k 1.2×	1.2k 1.2×	764 0.9×	485 0.6×	15	3.8k
Sigve Andersen Norway	33	1.6k 1.0×	2.0k 1.4×	1.4k 1.5×	981 1.1×	1.2k 1.4×	80	3.9k
Alexandre Calon Spain	15	1.6k 1.0×	2.7k 1.8×	981 1.1×	1.0k 1.2×	508 0.6×	23	4.0k
Karuna Ganesh United States	14	1.4k 0.8×	1.7k 1.2×	818 0.9×	828 1.0×	584 0.7×	37	3.4k
Robert D. Loberg United States	34	1.6k 0.9×	2.1k 1.4×	832 0.9×	1.0k 1.2×	920 1.1×	59	4.1k
Samer Al‐Saad Norway	36	1.7k 1.0×	2.3k 1.6×	1.3k 1.4×	1.3k 1.4×	1.2k 1.4×	66	4.3k
Jiang Liu China	17	1.9k 1.1×	1.4k 0.9×	1.1k 1.2×	901 1.0×	950 1.1×	33	3.4k
Sha Zhao China	30	1.5k 0.9×	1.4k 1.0×	745 0.8×	1.2k 1.3×	785 0.9×	97	3.4k

Countries citing papers authored by Andreas Pircher

Since Specialization

Citations

This map shows the geographic impact of Andreas Pircher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Pircher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Pircher more than expected).

Fields of papers citing papers by Andreas Pircher

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andreas Pircher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Pircher. The network helps show where Andreas Pircher may publish in the future.

Co-authorship network of co-authors of Andreas Pircher

This figure shows the co-authorship network connecting the top 25 collaborators of Andreas Pircher. A scholar is included among the top collaborators of Andreas Pircher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andreas Pircher. Andreas Pircher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mousa, Mira, Stefan Salcher, Christina Plattner, et al.. (2025). Unveiling the immunomodulatory dance: endothelial cells’ function and their role in non-small cell lung cancer. Molecular Cancer. 24(1). 21–21. 1 indexed citations

Trebo, Manuel, Isabel Heidegger, Theresa Hautz, et al.. (2024). Profiling low-mRNA content cells in complex human tissues using BD Rhapsody single-cell analysis. STAR Protocols. 5(4). 103475–103475. 2 indexed citations

Pircher, Andreas, Michael A. W. Eaton, Atsushi Hata, et al.. (2024). 117O Stereotactic body radiotherapy (SBRT) with pembrolizumab (pembro) for unresected stage I/II non-small cell lung cancer (NSCLC): The randomized, double-blind, phase III KEYNOTE-867 study. Immuno-Oncology Technology. 24. 100746–100746. 3 indexed citations

Schaefer, Benedikt, Sonja Wagner, Bernhard Glodny, et al.. (2024). Intravenous iron-induced hypophosphatemia and kidney stone disease. Bone Reports. 21. 101759–101759. 3 indexed citations

Pircher, Andreas, et al.. (2023). The LARP1 homolog Slr1p controls the stability and expression of proto-5′TOP mRNAs in fission yeast. Cell Reports. 42(10). 113226–113226. 5 indexed citations

Lanser, Lukas, Michaela Plaikner, Andrea Schroll, et al.. (2023). Tissue iron distribution in patients with anemia of inflammation: Results of a pilot study. American Journal of Hematology. 98(6). 890–899. 7 indexed citations

Wolf‎, Dominik, et al.. (2023). Lipid nanoparticles in the treatment of lung cancer—hype or hope?. memo - Magazine of European Medical Oncology. 16(3). 193–197. 6 indexed citations

Salcher, Stefan, et al.. (2021). The Biology of Classic Hairy Cell Leukemia. International Journal of Molecular Sciences. 22(15). 7780–7780. 9 indexed citations

Gunsilius, Eberhard, Andreas Chott, Andreas Peer, et al.. (2021). Death of unknown cause? Post-mortem diagnosis of fulminant course of an EBV-associated secondary hemophagocytic lymphohistiocytosis. memo - Magazine of European Medical Oncology. 14(3). 287–291.

10.

Horvath, Lena & Andreas Pircher. (2021). ASCO 2020 non-small lung cancer (NSCLC) personal highlights. memo - Magazine of European Medical Oncology. 14(1). 66–69. 27 indexed citations

11.

Brandtner, Anna, Georg Lehner, Andreas Pircher, Clemens Feistritzer, & Michael Joannidis. (2021). Differential procoagulatory response of microvascular, arterial and venous endothelial cells upon inflammation in vitro. Thrombosis Research. 205. 70–80. 17 indexed citations

12.

Horvath, Lena, et al.. (2020). Tumor Endothelial Cells (TECs) as Potential Immune Directors of the Tumor Microenvironment – New Findings and Future Perspectives. Frontiers in Cell and Developmental Biology. 8. 766–766. 134 indexed citations

13.

Heidegger, Isabel, Andreas Pircher, & Renate Pichler. (2019). Targeting the Tumor Microenvironment in Renal Cell Cancer Biology and Therapy. Frontiers in Oncology. 9. 490–490. 92 indexed citations

14.

Pircher, Andreas, Georg Schäfer, Andrea Eigentler, et al.. (2019). Robo 4 - the double-edged sword in prostate cancer: impact on cancer cell aggressiveness and tumor vasculature. International Journal of Medical Sciences. 16(1). 115–124. 3 indexed citations

15.

Lambrechts, Diether, Els Wauters, Bram Boeckx, et al.. (2018). Phenotype molding of stromal cells in the lung tumor microenvironment. Nature Medicine. 24(8). 1277–1289. 1037 indexed citations breakdown →

16.

Pichler, Renate, Josef Fritz, Susanne Sprung, et al.. (2018). Prognostic Value of Testing PD-L1 Expression After Radical Cystectomy in High-risk Patients. Clinical Genitourinary Cancer. 16(5). e1015–e1024. 13 indexed citations

17.

Pircher, Andreas. (2017). Revival of anti-angiogenic therapies in cancer—news on an old therapeutic concept. memo - Magazine of European Medical Oncology. 10(4). 185–186. 2 indexed citations

18.

Heidegger, Isabel, Eberhard Steiner, Helmut Klocker, et al.. (2015). High Risk of Under-Grading and -Staging in Prostate Cancer Patients Eligible for Active Surveillance. PLoS ONE. 10(2). e0115537–e0115537. 20 indexed citations

19.

Bohl, Stephan, Andreas Pircher, & Wolfgang Hilbe. (2011). Cancer Stem Cells: Characteristics and Their Potential Role for New Therapeutic Strategies. Onkologie. 34(5). 269–274. 16 indexed citations

20.

Tzankov, Alexandar, Johann Kern, Andreas Pircher, et al.. (2010). Increased Dkk3 protein expression in platelets and megakaryocytes of patients with myeloproliferative neoplasms. Thrombosis and Haemostasis. 105(1). 72–80. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact